These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 4464520

  • 21. Choline for blepharospasm.
    Skarf B, Sharpe JA.
    N Engl J Med; 1981 Oct 15; 305(16):957-8. PubMed ID: 7278904
    [No Abstract] [Full Text] [Related]

  • 22. Letter: Dimethyl aminoethanol in blepharospasm and hemifacial spasm.
    Dahdaleh MP, Small M, Thomas DJ.
    N Engl J Med; 1975 Jul 10; 293(2):98. PubMed ID: 1168855
    [No Abstract] [Full Text] [Related]

  • 23. [Treatment of blepharospasm by injections of botulinum toxin].
    Adenis JP, Lebraud P, Franco JL.
    Bull Soc Ophtalmol Fr; 1987 Jul 10; 87(6-7):761-2, 767. PubMed ID: 3664886
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [The use of botulinum toxin in ophthalmology].
    Lanzl I, Roggenkämper P, Merté RL.
    Klin Monbl Augenheilkd; 2014 Jul 10; 231(7):749-63. PubMed ID: 25036810
    [No Abstract] [Full Text] [Related]

  • 27. Botulinum A toxin in the treatment of blepharospasm.
    Jankovic J.
    Adv Neurol; 1988 Jul 10; 49():467-72. PubMed ID: 3278552
    [No Abstract] [Full Text] [Related]

  • 28. Botulinum toxin therapy for strabismus and blepharospasm: Bascom Palmer Eye Institute experience.
    Flynn JT, Bachynski B.
    Trans New Orleans Acad Ophthalmol; 1986 Jul 10; 34():73-88. PubMed ID: 3726970
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Motor fluctuations in Parkinson's disease: the "New frontier" of therapeutic success. A Roche Laboratory seminar].
    d'Anglejan Chatillon J.
    Rev Prat; 1989 Mar 09; 39(8):689-90. PubMed ID: 2727575
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Treatment of dystonic blepharospasm and hemifacial spasm with botulinum toxin: preliminary studies].
    Martí MJ, Kulisevsky J, Tolosa E.
    Med Clin (Barc); 1987 Sep 19; 89(8):321-3. PubMed ID: 3320608
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Dopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease.
    Vaamonde J, Luquin MR, Obeso JA.
    Mov Disord; 1990 Sep 19; 5(3):260-2. PubMed ID: 2388647
    [Abstract] [Full Text] [Related]

  • 37. Treatment of parkinsonian conditions with a controlled-release form of levodopa--preliminary study.
    Nordera GP, Lorizio A, Lion P, Durisotti C, D'Andrea G, Ferro-Milone F.
    Eur Neurol; 1987 Sep 19; 27 Suppl 1():76-80. PubMed ID: 3322839
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Current treatment strategies for Parkinson's disease].
    Südmeyer M, Wojtecki L, Schnitzler A.
    Fortschr Neurol Psychiatr; 2011 Dec 19; 79(12):733-43. PubMed ID: 22161168
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.